의약품 글리세린 시장 규모, 점유율 및 성장 분석 : 유형별, 원료별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global Pharmaceutical Glycerine Market size was valued at USD 41.08 Million in 2024 and is poised to grow from USD 43.83 Million in 2025 to USD 73.64 Million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is on an upward trajectory, driven by its applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. Increasing demand for cough syrups, wound care ointments, and glycerine-based capsules, particularly in emerging markets, is boosting glycerine consumption. Growth in the pharmaceutical sector, especially in Asia-Pacific and Latin America, coupled with advancements in manufacturing yielding higher purity products, accelerates this trend. The shift towards plant-derived glycerine aligns with the demand for sustainable, bio-based raw materials. However, challenges such as raw material supply fluctuations, production costs associated with pharmaceutical-grade certification, and disruptions in supply chains can impact pricing strategies and market dynamics, particularly for smaller manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing significant growth driven by its diverse applications in various drug formulations, including syrups, capsules, ointments, and drug delivery systems. This surge in demand is primarily attributed to the expanding pharmaceutical sector, particularly in emerging economies, where healthcare advancements are on the rise. Furthermore, the growing focus on biopharmaceutical production and the shift towards innovative and complex drug formulations are expected to further boost the need for premium pharmaceutical glycerine. Its attributes, such as safety, stability, and moisture retention, make glycerine an essential ingredient in this evolving landscape of pharmaceuticals.

Restraints in the Global Pharmaceutical Glycerine Market

The Global Pharmaceutical Glycerine market faces notable challenges due to its dependence on raw materials such as palm and soybean oils, which can experience market volatility. Factors such as climate change, trade limitations, and variations in the biodiesel sector can significantly impact the availability and pricing of glycerine. These fluctuations may lead to supply chain disruptions, making it difficult for manufacturers to maintain production schedules and profitability, particularly for smaller companies specializing in pharmaceutical excipients. Consequently, the market's stability may be jeopardized, affecting overall growth and competitiveness within the industry.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing a notable shift towards the adoption of plant-based glycerine, driven by increasing consumer demand for sustainability and vegan-friendly alternatives. This market trend is characterized by a growing preference for ethically sourced, clean-label products that adhere to higher standards of transparency and environmental responsibility. As pharmaceutical companies respond to consumer pressures and regulatory requirements, the transition from traditional animal-derived sources to plant-derived glycerine is gaining momentum, particularly in regions like Europe and North America. This shift not only reflects changing consumer preferences but also signals a broader commitment to sustainable practices within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

• Market Overview
• 99.7% Purity
• Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

• Market Overview
• Animal
• Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oral Use
• External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

• North America (Type, Source, Application)
  • US
  • Canada
• Europe (Type, Source, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Source, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Source, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Source, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IOI Oleo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK Oleo (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oleon NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P&G Chemicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Chemical Company (TCC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Godrej Industries Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twin Rivers Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVF LLC (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avril Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GLACONCHEMIE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rajaram Solvents Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3F Chimica SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvay SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peter Greven GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations